By Vin Gurrieri ( September 15, 2015, 10:02 PM EDT) -- Direct buyers of Provigil pressed a Pennsylvania federal court again Tuesday to modify a class certification order in the pay-for-delay litigation, saying the opposition by generic-drug makers Mylan Pharmaceuticals Inc. and Ranbaxy Pharmaceuticals Inc. runs contrary to basic antitrust principles....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.